RENAISSANCE TECHNOLOGIES LLC
Position in MTNB — Matinas BioPharma Holdings, Inc.
CIK 1037389
NEW YORK, NY
Position in MTNB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$43,476
+$29,191 QoQ
Shares Held
71,040
+148.7% QoQ
Ownership
0.484%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 25 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MTNB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. MTNB ranks #289 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MTNB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,476 | 71,040 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $14,285 | 28,570 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,976 | 28,970 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $53,430 | 28,270 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,956 | 24,670 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,632 | 22,370 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,266 | 18,170 | Shares | Sole | 2025-02-13 | |
| 2024-06-30 | $70,647 | 447,137 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $112,204 | 414,037 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $80,273 | 371,637 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,863 | 214,337 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $52,596 | 146,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $80,806 | 171,929 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $60,548 | 121,096 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $21,496 | 33,800 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $472,092 | 609,152 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $147,423 | 140,403 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,658,060 | 1,219,162 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $206,391 | 267,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $614,580 | 1,024,300 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||